Boston Children’s Hospital

Program Co-Director	Program Co-Director	Program Admin
Mark D. Kellogg, PhD, DABCC	Roy W.A. Peake, PhD, DABCC	David Dumais
Associate Director of Clinical Chemistry	Associate Director of Clinical Chemistry	Program Coordinator
mark.kellogg@childrens.harvard.edu	roy.peake@childrens.harvard.edu	David.Dumais@childrens.harvard.edu
(617) 355-7484	(617) 713-7608	(617) 713-7616

About the Program

The program at Boston Children’s Hospital (BCH) trains individuals for a career in academic clinical chemistry that includes service, teaching and research. BCH is a 404-bed comprehensive center for pediatric healthcare affiliated with Harvard Medical School.

During their 2-year fellowship at BCH, our fellows gain knowledge of the applications of clinical chemistry for the diagnosis and monitoring of human disease, including knowledge of laboratory techniques, instrumentation, test selection, quality control and management systems. Fellows also gain an understanding of clinical utilization and demand optimization strategies, and the interpretation of laboratory results, clinical liaison, and consultation with clinicians.

Our program encourages active participation in training and education related to laboratory medicine, including teaching analytical and clinical aspects of laboratory medicine to medical technologists, medical students, residents, fellows and other healthcare professionals. In year 2, our fellows will gain and further develop clinical, scientific and research skills.

The program is designed to foster an ability to conduct research autonomously in areas such as analytical method development using state-of-the-art instrumentation such as mass spectrometry, biomarker development or validation, and translational research. In addition to the co-directors, our program has a group of enthusiastic faculty who contribute to fellows training. We also pride ourselves in equipping our fellows with the experience and skills needed to as functional clinical chemists/laboratory directors in an academic medical center setting. We also believe strongly in the value of board certification and have a strong track record in board certification of our fellows.

Program Requirements

To be considered for the program, prospective fellows must have:

1. Applicants must possess an earned Doctor of Philosophy or an equivalent doctoral degree in biochemistry, physiology, chemistry or another of the natural sciences, or a Doctor of Medicine degree from an accredited university or college.
2. Applicants must have completed a minimum of 30 semester hours (or equivalent) in undergraduate and/or graduate level chemistry or biochemistry courses taken at accredited institutions.
   • Transcripts from foreign universities are evaluated by an evaluation service to determine equivalency with US based programs.

To Apply

Selection is an ongoing process. Start dates are flexible based on program and trainee desires, although all attempts are made to start training in August/September timeframe. Applications are reviewed by the program directors and then selected for interview. The interview process includes meeting with all program faculty and a presentation of research by the candidate trainee. Strong preference is given to those with prior experience in clinical laboratory medicine.

The application packet must include:

1. Letter of interest
2. Curriculum vitae
3. Three letters of references
4. Undergraduate and graduate transcripts, together with selected first author publications for initial consideration
   • Transcripts received from academic institutions outside the U.S. or Canada will require evaluation by a ComACC approved credentials evaluation service.

Training Level

Postdoctoral Training Level
Number of positions available per year: 1 per year
Duration of program: 2 years
Approximate annual salary or stipend: PGY Scale
Source of funding: Endowment
Current number of trainees: 1
Number of past graduates: 16

Faculty

Carlo Brugnara, MD	Sickle Cell Disease, Regulation of Cell Volume and Transport of Ions across the Cell Membrane
Michele Burns, MD	Clinical Toxicology
Christina Ellervik, MD, PhD	Bio-banking, Clinical Research Study Design, Statistics
Nicholas Heger, PhD, NRCC	Laboratory Automation, Toxicology, Therapeutic Drug Monitoring
Gary Horowitz, MD	Immunoglobulins, Protein Electrophoresis, Diagnostic Errors, Quality Management, Laboratory Informatics
Yachana Kataria, PhD, DABCC	General Clinical Chemistry, Clinical Epidemiology
Mark Kellogg, PhD, DABCC	Clinical Utilization of Mass Spectrometry, Pediatric Clinical Chemistry, Nutritional Modulation of Performance, Clinical Endocrinology
Stacy Melanson, MD, PhD	Toxicology, Pain Management, Therapeutic Drug Monitoring, Patient Safety, Laboratory Process Improvement
Roy Peake, PhD, DABCC, FACMG	Inborn Errors of Metabolism, Application of Chromatography – Mass Spectrometry to the Study of Metabolic Disorders
Nader Rifai, PhD, DABCC	Biomarker Validation, Editorial Activities/Publishing, Education, E-learning in Laboratory Medicine
Nicole Tolan, PhD, DABCC	General Clinical Chemistry, Point-of-Care Testing, Toxicology, Therapeutic Drug Monitoring